The Restoration of America Foundation (ROAF) is calling on the Senate Finance Committee to hold Secretary of Health and Human Services Robert F. Kennedy Jr. accountable regarding the recent rollback of safety protocols for the abortion pill, mifepristone.
Ahead of a scheduled Senate hearing at 10 a.m. on Thursday, the organization voiced strong concerns about the elimination of long-standing safeguards. ROAF is urging lawmakers to demand answers about the potential risks these policy changes may pose to women’s health and the added burden they may place on taxpayers.
Savannah Chrisley Opens Up About Complicated Relationship with Brother Chase Chrisley
ROAF’s Concerns Over Mifepristone Protocol Changes
In a letter to the committee, ROAF highlighted its deep concerns about the removal of safety protocols that had been in place for more than two decades. The group warned that lifting these measures could increase risks to women’s health and create financial consequences for the healthcare system.
At the center of the debate is the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. Historically, REMS protocols required in-person dispensing and medical screening to check for complications such as ectopic pregnancies. ROAF argues that removing these safeguards has placed women at greater risk.
Statement from ROAF Founder Doug Truax
ROAF founder and CEO Doug Truax strongly criticized the rollback of safety requirements:
“Important safety measures have been removed by ending the REMS requirements for mifepristone that have protected women’s health for decades. We urge the Senate to demand clear answers on why these protocols were lifted and when they will be reinstated.”
Changes in FDA Protocol for Mifepristone
Under past requirements, the FDA ensured that mifepristone was dispensed in person, giving healthcare providers the ability to examine women for possible complications before prescribing the drug.
However, the current administration removed these in-person requirements, allowing the pill to be prescribed via telehealth and mailed directly to patients.
According to Truax, this shift increases risks by enabling powerful medications to be ordered online without adequate medical oversight. He stressed that women must be fully informed about potential dangers and have immediate access to emergency care when needed.
Data on Chemical Abortions
Recent studies have added to concerns about chemical abortion safety. One report indicated that around 11 percent of chemical abortions resulted in serious health issues, such as excessive bleeding and infections. This figure is significantly higher than earlier FDA reports, raising questions about whether current safeguards are sufficient.
Looking Ahead: Senate Hearing on Mifepristone
As Secretary Kennedy prepares to testify before the Senate Finance Committee, the hearing is expected to spark debate over abortion safety protocols and the broader public health implications of these recent policy changes.
At the time of writing, the Department of Health and Human Services (HHS) has not issued an official response to ROAF’s concerns.
Conclusion
The upcoming Senate Finance Committee hearing represents a critical moment in the national debate over mifepristone safety measures. ROAF’s call for accountability underscores growing concerns about women’s health, public safety, and the long-term effects of loosening federal protections.
With potential consequences for both healthcare and society, attention now turns to Secretary Kennedy’s testimony and the discussions that follow.
1 thought on “Restoration of America Foundation (ROAF) Calls for Accountability in Senate Hearing on Mifepristone Safety Measures”